Bone Biologics Corp

NAS:BBLG (USA)  
$ 1.48 -0.045 (-2.95%) 12:06 PM EST
At Loss
P/B:
0.27
Enterprise V:
$ -1.69M
Volume:
11.99K
Avg Vol (2M):
103.59K
Volume:
11.99K
At Loss
Avg Vol (2M):
103.59K

Business Description

Bone Biologics Corp
NAICS : 325412 SIC : 3842
ISIN : US0980702049
Description
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.78
Interest Coverage No Debt
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 19.5
3-Year EPS without NRI Growth Rate 38.1
3-Year FCF Growth Rate -0.7
Name Current Vs Industry Vs History
5-Day RSI 22.6
9-Day RSI 28.08
14-Day RSI 31.67
6-1 Month Momentum % -48.86
12-1 Month Momentum % -96.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.5
Quick Ratio 4.5
Cash Ratio 3.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -118.6
Name Current Vs Industry Vs History
ROE % -211.95
ROA % -141.53
ROIC % -949.36
ROCE % -223.3

Financials (Next Earnings Date:2024-05-15 Est.)

BBLG's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BBLG

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Bone Biologics Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -76.501
Beta -0.17
Volatility % 95.74
14-Day RSI 31.67
14-Day ATR ($) 0.213739
20-Day SMA ($) 1.775395
12-1 Month Momentum % -96.28
52-Week Range ($) 1.46 - 71.999999
Shares Outstanding (Mil) 0.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bone Biologics Corp Filings

Filing Date Document Date Form
No Filing Data

Bone Biologics Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Bone Biologics Corp Frequently Asked Questions

What is Bone Biologics Corp(BBLG)'s stock price today?
The current price of BBLG is $1.48. The 52 week high of BBLG is $72.00 and 52 week low is $1.46.
When is next earnings date of Bone Biologics Corp(BBLG)?
The next earnings date of Bone Biologics Corp(BBLG) is 2024-05-15 Est..
Does Bone Biologics Corp(BBLG) pay dividends? If so, how much?
Bone Biologics Corp(BBLG) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1